These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35900204)

  • 21. A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee.
    Spierings ELH; Fidelholtz J; Wolfram G; Smith MD; Brown MT; West CR
    Pain; 2013 Sep; 154(9):1603-1612. PubMed ID: 23707270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence.
    Zhang W; Moskowitz RW; Nuki G; Abramson S; Altman RD; Arden N; Bierma-Zeinstra S; Brandt KD; Croft P; Doherty M; Dougados M; Hochberg M; Hunter DJ; Kwoh K; Lohmander LS; Tugwell P
    Osteoarthritis Cartilage; 2007 Sep; 15(9):981-1000. PubMed ID: 17719803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of topical diclofenac sodium gel for knee osteoarthritis in elderly and younger patients: pooled data from three randomized, double-blind, parallel-group, placebo-controlled, multicentre trials.
    Baraf HS; Gloth FM; Barthel HR; Gold MS; Altman RD
    Drugs Aging; 2011 Jan; 28(1):27-40. PubMed ID: 21174485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period.
    Berenbaum F; Blanco FJ; Guermazi A; Miki K; Yamabe T; Viktrup L; Junor R; Carey W; Brown MT; West CR; Verburg KM
    Ann Rheum Dis; 2020 Jun; 79(6):800-810. PubMed ID: 32234715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tramadol for osteoarthritis.
    Toupin April K; Bisaillon J; Welch V; Maxwell LJ; Jüni P; Rutjes AW; Husni ME; Vincent J; El Hindi T; Wells GA; Tugwell P
    Cochrane Database Syst Rev; 2019 May; 5(5):CD005522. PubMed ID: 31132298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial.
    Schnitzer TJ; Easton R; Pang S; Levinson DJ; Pixton G; Viktrup L; Davignon I; Brown MT; West CR; Verburg KM
    JAMA; 2019 Jul; 322(1):37-48. PubMed ID: 31265100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical nonsteroidal anti-inflammatory drugs in the treatment of knee osteoarthritis: a systematic review and meta-analysis.
    Wolff DG; Christophersen C; Brown SM; Mulcahey MK
    Phys Sportsmed; 2021 Nov; 49(4):381-391. PubMed ID: 33554694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of intravenous tanezumab for the symptomatic treatment of osteoarthritis: 2 randomized controlled trials versus naproxen.
    Ekman EF; Gimbel JS; Bello AE; Smith MD; Keller DS; Annis KM; Brown MT; West CR; Verburg KM
    J Rheumatol; 2014 Nov; 41(11):2249-59. PubMed ID: 25274899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011535. PubMed ID: 33871055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of fulranumab as monotherapy in patients with moderate to severe, chronic knee pain of primary osteoarthritis: a randomised, placebo- and active-controlled trial.
    Mayorga AJ; Wang S; Kelly KM; Thipphawong J
    Int J Clin Pract; 2016 Jun; 70(6):493-505. PubMed ID: 27238963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetaminophen for osteoarthritis.
    Towheed TE; Judd MJ; Hochberg MC; Wells G
    Cochrane Database Syst Rev; 2003; (2):CD004257. PubMed ID: 12804508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nerve Growth Factor Antagonists: Is the Future of Monoclonal Antibodies Becoming Clearer?
    Bannwarth B; Kostine M
    Drugs; 2017 Sep; 77(13):1377-1387. PubMed ID: 28660479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-intensity versus low-intensity physical activity or exercise in people with hip or knee osteoarthritis.
    Regnaux JP; Lefevre-Colau MM; Trinquart L; Nguyen C; Boutron I; Brosseau L; Ravaud P
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010203. PubMed ID: 26513223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nerve growth factor: an update on the science and therapy.
    Seidel MF; Wise BL; Lane NE
    Osteoarthritis Cartilage; 2013 Sep; 21(9):1223-8. PubMed ID: 23973134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
    Chen YF; Jobanputra P; Barton P; Bryan S; Fry-Smith A; Harris G; Taylor RS
    Health Technol Assess; 2008 Apr; 12(11):1-278, iii. PubMed ID: 18405470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paracetamol versus placebo for knee and hip osteoarthritis.
    Leopoldino AO; Machado GC; Ferreira PH; Pinheiro MB; Day R; McLachlan AJ; Hunter DJ; Ferreira ML
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013273. PubMed ID: 30801133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Efficacy, Tolerability, and Joint Safety of Fasinumab in Osteoarthritis Pain: A Phase IIb/III Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Dakin P; DiMartino SJ; Gao H; Maloney J; Kivitz AJ; Schnitzer TJ; Stahl N; Yancopoulos GD; Geba GP
    Arthritis Rheumatol; 2019 Nov; 71(11):1824-1834. PubMed ID: 31207169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome measures in placebo-controlled trials of osteoarthritis: responsiveness to treatment effects in the REPORT database.
    Dworkin RH; Peirce-Sandner S; Turk DC; McDermott MP; Gibofsky A; Simon LS; Farrar JT; Katz NP
    Osteoarthritis Cartilage; 2011 May; 19(5):483-92. PubMed ID: 21396467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arthroscopic lavage and debridement for osteoarthritis of the knee: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(12):1-37. PubMed ID: 23074463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.